Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant

Human Immunology

Volumn 72, Issue 2, 2011, Pages 139-143

  Sellami, Mohamed Hichem ^a   Bani, Meriem ^a   Torjemane, Lamia ^a   Kaabi, Houda ^a   Ladeb, Saloua ^b   Othmane, Tarek Ben ^b   Hmida, Slama ^a  

^a Centre National de Transfusion Sanguine Tunis   (Tunisia)

^b CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

Author keywords

CTLA 4; GVHD; HSCT; Polymorphism; Tunisians

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETOPOSIDE; FLUDARABINE; HLA ANTIGEN; METHOTREXATE; NUCLEOTIDE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DONOR; FANCONI ANEMIA; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SCHOOL CHILD; SIBLING; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA; TUNISIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALLELES; ANTIGENS, CD; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TUNISIA; YOUNG ADULT;

EID: 78651243291     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.11.008     Document Type: Article

References (26)

1. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
2. Jenq R.R., Van den Brink M.R. Allogeneic haematopoietic stem cell transplantation: Individualized stem cell and immune therapy of cancer. Nat Rev Cancer 2010, 10:213-221.
3. Paczesny S., Hanauer D., Sun Y., Reddy P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010, 45:1-11.
4. Sun Y., Tawara I., Toubai T., Reddy P. Pathophysiology of Acute graft-vs-host disease: Recent advances. Transl Res 2007, 150:197-214.
5. Spencer C.T., Gilchuk P., Dragovic S.M., Joyce S. Minor histocompatibility antigens: Presentation principles, recognition logic and the potential for a healing hand. Curr Opin Organ Transplant 2010, 15:512-525.
6. Socie G., Blazar B.R. Acute graft-versus-host disease: From the bench to the bedside. Blood 2009, 114:4327-4336.
7. Teft W.A., Kirchhof M.G., Madrenas J. A molecular perspective of Ctla-4 function. Annu Rev Immunol 2006, 24:65-97.
8. Chikuma S., Bluestone J.A. CTLA-4 and Tolerance. The Biochemical Point of View. Immunol Res 2003, 28:241-253.
9. Paterson A.M., Sharpe A.H. Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells. Nat Immunol 2010, 11:109-111.
10. Sun T., Hu Z., Shen H., Lin D. Genetic Polymorphisms in cytotoxic T-lymphocyte Antigen 4 and Cancer: The Dialectical Nature of Subtle Human Immune dysregulation. Cancer Res 2009, 69:6011-6014.
11. Ligers A., Teleshova N., Masterman T., Huang W.X., Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001, 2:145-152.
12. Wang X.B., Zhao X., Giscombe R., Lefvert A.K. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002, 3:233-234.
13. Chistiakov D.A., Savost'anov K.V., Turakulov R.I., Efremov I.A., Demurov L.M. Genetic analysis and functional evaluation of the C/T (-318) and A/G (-1661 polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clin Immunol 2006, 118:233-242.
14. Sun T., Zhou Y., Yang M., Hu Z., Tan W., Han X., et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 2008, 68:7025-7034.
15. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
16. Pérez-García A., De la Cámara R., Román-Gómez J., Jiménez-Velasco A., Encuentra M., Nieto J.B., et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 2007, 110:461-467.
17. Vannucchi A.M., Guidi S., Guglielmelli P., Glinz S., Lombardini L., Busca A., et al. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation. Bone Marrow Transplant 2007, 40:1001.
18. Azarian M., Busson M., Lepage V., Charron D., Toubert A., Loiseau P., et al. Donor CTLA-4 + 49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. Blood 2007, 110:4623-4624.
19. Wu J., Tang J.L., Wu S.J., Lio H.Y., Yang Y.C. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation. Clin Chim Acta 2009, 403:229-233.
20. Przepiorka D., Weisdorf D., Martin P., Klingemann H.G., Beatty P., Hows J., et al. Meeting report: Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
21. Martin T.M., Bye L., Modi N., Stanford M.R., Vaughan R., Smith J.R., et al. Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis 2009, 15:208-212.
22. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
23. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
24. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., De Groot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves disease. J Immunol 2000, 165:6606-6611.
25. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.C., Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 2002, 277:46478-46486.
26. Xu Y., Graves P.N., Tomer Y., Davies T.F. CTLA-4 and autoimmune thyroid disease: Lack of influence of the A49G signal peptide polymorphismon functional recombinant human CTLA-4. Cell Immunol 2002, 215:133-140.